Life before Seventeen: Cloning of the IL-17 Receptor
Open accessThe DOI matches its Crossref record; 50 of the 51 references it cites were found in a registry or an index.
Abstract
It is often said that pathogens know more about the immune system than we do. For example, nearly all viruses have evolved some means of evading or counteracting viral pattern recognition receptor and IFN signaling pathways ([1][1], [2][2]). Many large DNA viruses, such as herpesviruses and
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“both the ligand and receptor were distinct in sequence from other known mammalian cytokines.”
From The IL-17 Family of Cytokines in Health and Disease (2019) · cites this paper as Gaffen, 2011
In the citing paper
“showed unexpected sequence homology with an open reading frame in Herpesvirus saimiri, a T cell tropic γ-herpesvirus, but not with other known cytokine families”
From The IL-17 Family of Cytokines in Health and Disease (2019) · cites this paper as Gaffen, 2011
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Doreau, A., Belot, A., Bastid, J., Riche, B., Trescol-Biemont, M.-C., Ranchin, B., Fabien, N., Cochat, P., Pouteil-Noble, C., Trolliet, P., et al. (2009) · Nature Immunology · doi:10.1038/ni.1741 · Cited by 452
RetractedKorn, T., Bettelli, E., Oukka, M., & Kuchroo, V. K. (2009) · Annual Review of Immunology · doi:10.1146/annurev.immunol.021908.132710 · Cited by 4,873 · cited 1×
“The discovery of this subset in 2005 triggered a more nuanced appreciation of T cell immunology (33, 34), reviewed extensively elsewhere (35).”
BackgroundHarrington, L. E., Hatton, R. D., Mangan, P. R., Turner, H., Murphy, T. L., Murphy, K. M., & Weaver, C. T. (2005) · Nature Immunology · doi:10.1038/ni1254 · Cited by 4,742 · cited 1×
“The discovery of this subset in 2005 triggered a more nuanced appreciation of T cell immunology (33, 34), reviewed extensively elsewhere (35).”
BackgroundA distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17
Park, H., Li, Z., Yang, X. O., Chang, S. H., Nurieva, R., Wang, Y.-H., Wang, Y., Hood, L., Zhu, Z., Tian, Q., et al. (2005) · Nature Immunology · doi:10.1038/ni1261 · Cited by 4,265 · cited 1×
“The discovery of this subset in 2005 triggered a more nuanced appreciation of T cell immunology (33, 34), reviewed extensively elsewhere (35).”
BackgroundInterleukin-17 Family Members and Inflammation
Kolls, J. K., & Lindén, A. (2004) · Immunity · doi:10.1016/j.immuni.2004.08.018 · Cited by 2,372 · cited 1×
“IL-17 is produced not only by CD4(1) Th cells but also by a variety of innate lymphocytes, including gdT and NKT cells (36), and is a major regulator of the neutrophil response (37, 38).”
BackgroundInnate IL-17-producing cells: the sentinels of the immune system
Cua, D. J., & Tato, C. M. (2010) · Nature Reviews Immunology · doi:10.1038/nri2800 · Cited by 1,578
Randall, R. E., & Goodbourn, S. (2008) · Journal of General Virology · doi:10.1099/vir.0.83391-0 · Cited by 1,571 · cited 1×
“ruses have evolved some means of evading or counteracting viral pattern recognition receptor and IFN signaling pathways (1, 2).”
BackgroundYe, P., Rodriguez, F. H., Kanaly, S., Stocking, K. L., Schurr, J., Schwarzenberger, P., Oliver, P., Huang, W., Zhang, P., Zhang, J., et al. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.194.4.519 · Cited by 1,521 · cited 1×
“These features of IL-17 are consistent with its rapid action in primary infections, first documented for Klebsiella pneumoniae (39) but since observed in numerous infectious disease settings (40).”
BackgroundStructure and signalling in the IL-17 receptor family
Gaffen, S. L. (2009) · Nature reviews. Immunology · doi:10.1038/nri2586 · Cited by 1,475 · cited 1×
“A variety of studies evaluating IL-17R signal transduction are beginning to reveal the detailed modes of action of this intriguing receptor family (23, 24).”
BackgroundSelf-citationSteinman, L. (2007) · Nature Medicine · doi:10.1038/nm1551 · Cited by 1,376
Functional Specialization of Interleukin-17 Family Members
Iwakura, Y., Ishigame, H., Saijo, S., & Nakae, S. (2011) · Immunity · doi:10.1016/j.immuni.2011.02.012 · Cited by 1,289
STAT3 Mutations in the Hyper-IgE Syndrome
Holland, S. M., DeLeo, F. R., Elloumi, H. Z., Hsu, A. P., Uzel, G., Brodsky, N., Freeman, A. F., Demidowich, A., Davis, J., Turner, M. L., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa073687 · Cited by 1,221 · cited 1×
“Similarly, individuals with inherited defects in IL-17F, IL-17RA, or STAT3 (required for Th17 differentiation) also exhibit mucosal candidiasis and cutaneous staphylococcal infections (42, 43), consistent with prior mouse studies (44–47).”
ResultChronic Mucocutaneous Candidiasis in Humans with Inborn Errors of Interleukin-17 Immunity
Puel, A., Cypowyj, S., Bustamante, J., Wright, J. F., Liu, L., Lim, H. K., Migaud, M., Israel, L., Chrabieh, M., Audry, M., et al. (2011) · Science · doi:10.1126/science.1200439 · Cited by 1,056 · cited 1×
“Similarly, individuals with inherited defects in IL-17F, IL-17RA, or STAT3 (required for Th17 differentiation) also exhibit mucosal candidiasis and cutaneous staphylococcal infections (42, 43), consistent with prior mouse studies (44–47).”
ResultConti, H. R., Shen, F., Nayyar, N., Stocum, E., Sun, J. N., Lindemann, M. J., Ho, A. W., Hai, J. H., Yu, J. J., Jung, J. W., et al. (2009) · Journal of Experimental Medicine · doi:10.1084/jem.20081463 · Cited by 1,024
Human IL-17: a novel cytokine derived from T cells
Yao, Z., Painter, S. L., Fanslow, W. C., Ulrich, D., Macduff, B. M., Spriggs, M. K., & Armitage, R. J. (1995) · The Journal of Immunology · doi:10.4049/jimmunol.155.12.5483 · Cited by 1,021
Herpesvirus Saimiri encodes a new cytokine, IL-17, which binds to a novel cytokine receptor
Yao, Z., Fanslow, W. C., Seldin, M. F., Rousseau, A.-M., Painter, S. L., Comeau, M. R., Cohen, J. I., & Spriggs, M. K. (1995) · Immunity · doi:10.1016/1074-7613(95)90070-5 · Cited by 994 · cited 2×
“(5) demonstrated activation of NF-kB in 3T3 fibroblasts, as well as IL-17–induced secretion of IL-6, an NF-kB–dependent”
BackgroundMethodInterleukin-17 family and IL-17 receptors
Moseley, T. A., Haudenschild, D. R., Rose, L., & Reddi, A. H. (2003) · Cytokine & Growth Factor Reviews · doi:10.1016/s1359-6101(03)00002-9 · Cited by 918 · cited 9×
“IL-17s adopt a cystine knot fold: structure and activity of a novel cytokine, IL-17F, and implications for receptor binding.”
BackgroundInfluentialHueber, W., Patel, D. D., Dryja, T., Wright, A. M., Koroleva, I., Bruin, G., Antoni, C., Draelos, Z., Gold, M. H., the Psoriasis Study Group, et al. (2010) · Science Translational Medicine · doi:10.1126/scitranslmed.3001107 · Cited by 860 · cited 1×
“Conversely, Th17 cells and IL-17 itself promote pathology in autoimmune disease models, inspiring clinical trials of anti–IL-17A Abs as therapies for various autoimmune disorders (48, 49).”
BackgroundRouvier, E., Luciani, M. F., Mattéi, M. G., Denizot, F., & Golstein, P. (1993) · The Journal of Immunology · doi:10.4049/jimmunol.150.12.5445 · Cited by 775 · cited 8×
“A particularly novel aspect of this discovery was the 57% identity between CTLA8 and ORF13 in Herpesvirus saimiri (HVS), a T cell tropic g-herpesvirus that causes a lymphoproliferative syndrome in New World primates.”
MethodInfluentialViral evasion and subversion of pattern-recognition receptor signalling
Bowie, A. G., & Unterholzner, L. (2008) · Nature Reviews Immunology · doi:10.1038/nri2436 · Cited by 746 · cited 1×
“ruses have evolved some means of evading or counteracting viral pattern recognition receptor and IFN signaling pathways (1, 2).”
BackgroundHsu, H.-C., Yang, P., Wang, J., Wu, Q., Myers, R., Chen, J., Yi, J., Guentert, T., Tousson, A., Stanus, A. L., et al. (2008) · Nature Immunology · doi:10.1038/ni1552 · Cited by 716 · cited 1×
“To date, very little follow-up has been done on the role of IL-17 activation of T cells, although direct effects in B lymphocytes have been convincingly documented (25, 26).”
BackgroundIL-17 is essential for host defense against cutaneous Staphylococcus aureus infection in mice
Cho, J. S., Pietras, E. M., Garcia, N. C., Ramos, R. I., Farzam, D. M., Monroe, H. R., Magorien, J. E., Blauvelt, A., Kolls, J. K., Cheung, A. L., et al. (2010) · Journal of Clinical Investigation · doi:10.1172/jci40891 · Cited by 658
Qian, Y., Liu, C., Hartupee, J., Altuntas, C. Z., Gulen, M. F., Jane-wit, D., Xiao, J., Lu, Y., Giltiay, N., Liu, J., et al. (2007) · Nature Immunology · doi:10.1038/ni1439 · Cited by 614 · cited 1×
“Proof that Act1 was indeed essential for IL-17R signaling soon followed with studies of EAE and IL-17 signaling in Act1 mice (16, 17).”
BackgroundIL-17: prototype member of an emerging cytokine family
Aggarwal, S., & Gurney, A. L. (2002) · Journal of Leukocyte Biology · doi:10.1189/jlb.71.1.1 · Cited by 597 · cited 8×
“IL-17s adopt a cystine knot fold: structure and activity of a novel cytokine, IL-17F, and implications for receptor binding.”
BackgroundInfluentialCutting Edge: Interleukin 17 Signals through a Heteromeric Receptor Complex
Toy, D., Kugler, D., Wolfson, M., Bos, T. V., Gurgel, J., Derry, J., Tocker, J., & Peschon, J. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.1.36 · Cited by 570 · cited 1×
“One of these, IL-17RC, was found to be an obligate coreceptor for IL-17 and IL-17F signaling in fibroblasts (10) and was recently confirmed to be essential in a variety of IL-17–dependent disease settings (11, 12).”
BackgroundHymowitz, S. G., Filvaroff, E. H., Yin, J., Lee, J., Cai, L., Risser, P., Maruoka, M., Mao, W., Foster, J., Kelley, R. F., et al. (2001) · The EMBO Journal · doi:10.1093/emboj/20.19.5332 · Cited by 548 · cited 1×
“The first crystal structure of an IL-17 family member (IL-17F) revealed unexpected similarity to cysteine-knot growth factors such as NGF (9).”
BackgroundGenovese, M. C., Van den Bosch, F., Roberson, S. A., Bojin, S., Biagini, I. M., Ryan, P., & Sloan‐Lancaster, J. (2010) · Arthritis & Rheumatism · doi:10.1002/art.27334 · Cited by 451 · cited 1×
“Conversely, Th17 cells and IL-17 itself promote pathology in autoimmune disease models, inspiring clinical trials of anti–IL-17A Abs as therapies for various autoimmune disorders (48, 49).”
BackgroundAct1 adaptor protein is an immediate and essential signaling component of interleukin-17 receptor
Chang, S. H., Park, H., & Dong, C. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.c600256200 · Cited by 356 · cited 1×
“Proof that Act1 was indeed essential for IL-17R signaling soon followed with studies of EAE and IL-17 signaling in Act1 mice (16, 17).”
BackgroundRickel, E. A., Siegel, L. A., Yoon, B.-R. P., Rottman, J. B., Kugler, D. G., Swart, D. A., Anders, P. M., Tocker, J. E., Comeau, M. R., & Budelsky, A. L. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.6.4299 · Cited by 321 · cited 1×
“IL-17RA also pairs with IL17RB to form the IL-25/IL-17E receptor (22) and may participate in other receptor complexes.”
BackgroundIdentification of Sef, a novel modulator of FGF signalling
Tsang, M., Friesel, R., Kudoh, T., & Dawid, I. B. (2002) · Nature Cell Biology · doi:10.1038/ncb749 · Cited by 304
The STIR-domain superfamily in signal transduction, development and immunity
Novatchkova, M., Leibbrandt, A., Werzowa, J., Neubüser, A., & Eisenhaber, F. (2003) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(03)00067-7 · Cited by 255 · cited 6×
“A landmark 2003 bioinformatic study identified a region located within IL-17R family cytoplasmic tails homologous to Toll-IL-1R (TIR) domains, dubbed a “SEFIR” (14).”
BackgroundInfluentialCytokine-mediated regulation of CXCR4 expression in human neutrophils
Nagase, H., Miyamasu, M., Yamaguchi, M., Imanishi, M., Tsuno, N. H., Matsushima, K., Yamamoto, K., Morita, Y., & Hirai, K. (2002) · Journal of Leukocyte Biology · doi:10.1189/jlb.71.4.711 · Cited by 240
Precarious Balance: Th17 Cells in Host Defense
Peck, A., & Mellins, E. D. (2010) · Infection and Immunity · doi:10.1128/iai.00929-09 · Cited by 236 · cited 1×
“These features of IL-17 are consistent with its rapid action in primary infections, first documented for Klebsiella pneumoniae (39) but since observed in numerous infectious disease settings (40).”
BackgroundAct1, a U-box E3 Ubiquitin Ligase for IL-17 Signaling
Liu, C., Qian, W., Qian, Y., Giltiay, N. V., Lu, Y., Swaidani, S., Misra, S., Deng, L., Chen, Z. J., & Li, X. (2009) · Science Signaling · doi:10.1126/scisignal.2000382 · Cited by 224 · cited 1×
“Act1 is both an adaptor for TRAFs and an E3 ubiquitin ligase necessary for NF-kB activation by IL-17 (18).”
BackgroundKagami, S., Rizzo, H. L., Kurtz, S. E., Miller, L. S., & Blauvelt, A. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.1001153 · Cited by 216
Structural basis of receptor sharing by interleukin 17 cytokines
Ely, L. K., Fischer, S., & Garcia, K. C. (2009) · Nature Immunology · doi:10.1038/ni.1813 · Cited by 195 · cited 1×
“the unique nature of the receptor’s overall architecture (13).”
BackgroundInterleukin-17: A novel inflammatory cytokine that bridges innate and adaptive immunity
Yu, J. (2008) · Frontiers in Bioscience · doi:10.2741/2667 · Cited by 178
Maitra, A., Shen, F., Hanel, W., Mossman, K., Tocker, J., Swart, D., & Gaffen, S. L. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0611589104 · Cited by 165
Hu, Y., Ota, N., Peng, I., Refino, C. J., Danilenko, D. M., Caplazi, P., & Ouyang, W. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0903614 · Cited by 153
Act1, a negative regulator in CD40- and BAFF-mediated B cell survival
Qian, Y., Qin, J., Cui, G., Naramura, M., Snow, E. C., Ware, C. F., Fairchild, R. L., Omori, S. A., Rickert, R. C., Scott, M., et al. (2004) · Immunity · doi:10.1016/j.immuni.2004.09.001 · Cited by 143 · cited 2×
“Act1, a negative regulator in CD40- and BAFF-mediated B cell survival.”
BackgroundInborn errors of mucocutaneous immunity to Candida albicans in humans: a role for IL-17 cytokines?
Puel, A., Picard, C., Cypowyj, S., Lilic, D., Abel, L., & Casanova, J.-L. (2010) · Current Opinion in Immunology · doi:10.1016/j.coi.2010.06.009 · Cited by 140
Roberts, S., Gueguen, Y., de Lorgeril, J., & Goetz, F. W. (2008) · Developmental & Comparative Immunology · doi:10.1016/j.dci.2008.02.006 · Cited by 128
Pancer, Z., Mayer, W. E., Klein, J., & Cooper, M. D. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0405529101 · Cited by 127
Ho, A. W., Shen, F., Conti, H. R., Patel, N., Childs, E. E., Peterson, A. C., Hernández-Santos, N., Kolls, J. K., Kane, L. P., Ouyang, W., et al. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0903739 · Cited by 125
Schwarzenberger, P., & Kolls, J. K. (2002) · Journal of Cellular Biochemistry · doi:10.1002/jcb.10054 · Cited by 60
SEF/IL-17R (SEFIR) Is Not Enough
Onishi, R. M., Park, S. J., Hanel, W., Ho, A. W., Maitra, A., & Gaffen, S. L. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.121418 · Cited by 56
Lamprey (Lethenteron japonicum) IL-17 upregulated by LPS-stimulation in the skin cells
Tsutsui, S., Nakamura, O., & Watanabe, T. (2007) · Immunogenetics · doi:10.1007/s00251-007-0254-2 · Cited by 55
The Interleukin-17 Gene of Herpesvirus Saimiri
Knappe, A., Hiller, C., Niphuis, H., Fossiez, F., Thurau, M., Wittmann, S., Kuhn, E.-M., Lebecque, S., Banchereau, J., Rosenwirth, B., et al. (1998) · Journal of Virology · doi:10.1128/jvi.72.7.5797-5801.1998 · Cited by 46 · cited 1×
“impact viral replication, T cell transformation capacity, or viral pathogenicity (27).”
BackgroundRyzhakov, G., Blazek, K. D., & Udalova, I. A. (2011) · Journal of Molecular Evolution · doi:10.1007/s00239-011-9450-7 · Cited by 23 · cited 1×
“throughout evolution (19), empirical mapping studies of IL17RA and IL-17RC revealed that substantial nonconserved sequences downstream of the SEFIR are additionally required Division of Rheumatology and Clinical Immunology, Department of Medicine, University of Pittsburgh, Pittsburgh, PA 15261”
BackgroundViral TNF Inhibitors as Potential Therapeutics
Rahman, M. M., Lucas, A., & McFadden, G. (2009) · Advances in experimental medicine and biology · doi:10.1007/978-1-4419-1601-3_5 · Cited by 20 · cited 1×
“However, exploiting this knowledge has been a fruitful means of discovering new pathways important for microbial pathogenesis, as well as identifying potential therapeutic strategies that may be harnessed for clinical benefit (3).”
Background
Cited by
The IL-17 Family of Cytokines in Health and Disease
McGeachy, M. J., Cua, D. J., & Gaffen, S. L. (2019) · Immunity · doi:10.1016/j.immuni.2019.03.021 · Cited by 1,443
“Originally named CTLA8, the founding member of the family IL-17A showed unexpected sequence homology with an open reading frame in Herpesvirus saimiri, a T cell tropic γherpesvirus, but not with other known cytokine families (Gaffen, 2011; Yao et al., 1995a).”
BackgroundInfluentialSelf-citationKaymaz, K., & Beikler, T. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20143394 · Cited by 534
“The IL-17 receptor (IL-17R) lacks a homologous structure to other proteins; therefore, IL-17 cytokines are classified as a distinct family [53].”
BackgroundInterleukin 17 is a chief orchestrator of immunity
Veldhoen, M. (2017) · Nature Immunology · doi:10.1038/ni.3742 · Cited by 475
Ruiz de Morales, J. M. G., Puig, L., Daudén, E., Cañete, J. D., Pablos, J. L., Martín, A. O., Juanatey, C. G., Adán, A., Montalbán, X., Borruel, N., et al. (2020) · Autoimmunity Reviews · doi:10.1016/j.autrev.2019.102429 · Cited by 338
Interleukin-17A: The Key Cytokine in Neurodegenerative Diseases
Chen, J., Liu, X., & Zhong, Y. (2020) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2020.566922 · Cited by 165
“Initially termed CTLA8, IL-17A was cloned firstly in 1993 from a cDNA library of subtractive rodents and the IL-17-binding receptor was first reported in 1995 (Rouvier et al., 1993; Gaffen, 2011a).”
Background
Metadata
- Authors
- Gaffen, S. L.
- Affiliations
- University of Pittsburgh (US)
- Corresponding author
- Gaffen, Sarah L
- ORCID
- Gaffen, Sarah L
- Venue
- The Journal of Immunology
- Publisher
- Oxford University Press (OUP)
- Published
- 2011-11-01
- Volume
- 187
- Issue
- 9
- Pages
- 4389-4391
- ISSN
- 0022-1767 (ISSN-L)
- 1550-6606
- PMC
- PMC4824884
- OpenAlex
- W2126237738
- Cited by
- 22
- References
- 51
- Citations by year
- 2024: 2 · 2023: 6 · 2022: 4 · 2021: 2 · 2020: 1 · 2019: 4 · 2018: 1 · 2017: 1 · 2014: 1
- FWCI
- 0.16
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- The Journal of Immunology (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- Amgen
- National Institute of Allergy and Infectious Diseases (AI89768, R56AI089768)
- National Institute of Arthritis and Musculoskeletal and Skin Diseases (AR054389, R01AR054389)
- National Institute of Dental and Craniofacial Research (DE019424, R01DE019424)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Cytokine Signaling Pathways and Interactions
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Life Sciences › Immunology and Microbiology › Immunology › interferon and immune responses
- Keywords
- IL-17 receptor, receptor cloning, IL-17 signaling, innate immunity, viral evasion, pattern recognition receptors, interferon signaling, herpesvirus, DNA viruses
- MeSH terms
- Animals, Herpesvirus 2, Saimiriine, Humans, Repressor Proteins, Trans-Activators, Interleukin-17, Receptors, Interleukin-17
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.